Jianmin Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 5/6
Jianmin Pharmaceutical GroupLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥84.4M, which brings its debt-to-equity ratio to 3.6%. Its total assets and total liabilities are CN¥4.3B and CN¥2.0B respectively. Jianmin Pharmaceutical GroupLtd's EBIT is CN¥293.0M making its interest coverage ratio -1.2. It has cash and short-term investments of CN¥943.1M.
Key information
3.6%
Debt to equity ratio
CN¥84.40m
Debt
Interest coverage ratio | -1.2x |
Cash | CN¥943.12m |
Equity | CN¥2.36b |
Total liabilities | CN¥1.98b |
Total assets | CN¥4.33b |
Recent financial health updates
Recent updates
We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt
Jun 30We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease
May 21We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings
Apr 26Financial Position Analysis
Short Term Liabilities: 600976's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥1.9B).
Long Term Liabilities: 600976's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥72.3M).
Debt to Equity History and Analysis
Debt Level: 600976 has more cash than its total debt.
Reducing Debt: 600976's debt to equity ratio has increased from 0% to 3.6% over the past 5 years.
Debt Coverage: 600976's debt is well covered by operating cash flow (336%).
Interest Coverage: 600976 earns more interest than it pays, so coverage of interest payments is not a concern.